Message to Clients: COVID-19 Updates

March 19, 2020

With updates occurring every day regarding COVID-19 impact on businesses, we wanted to reach out concerning SafeBridge operations specifically. First and foremost, we are reiterating our company's hope that you are staying safe and remain healthy. We know that you depend on SafeBridge to be responsive to your business challenges and ongoing work. We will update this page as new information becomes available, so please check periodically.

The SafeBridge team continues to operate in all aspects of our business but are following the limitations recommended and, in some cases, mandated by local, state, and national authorities. As a service provider to the pharma/biotech industry, which is considered an “essential business,” our laboratory is still accepting analytical work for business critical and “rush” industrial hygiene samples. However, employees and lab personnel who can work from home are being allowed to do so.

While we remain open for business, we are taking the following steps to protect our staff and to support you, our client:

Health Considerations for Our Employees - We continue to follow guidance and align our procedures with the CDC, WHO, and relevant government authorities. We are limiting our employees to only essential travel and laboratory work. Our policy and requests for travel are being reviewed daily.

Flexible Work Arrangements  - Where not required by law, we are enabling our staff to work from home for anyone who needs this flexibility. Our technology and collaboration tools allow us to effectively continue to serve our clients.

Proactive Communication - We are in regular communication with our staff and our clients as we continue to adapt, protect, and maintain our services in the evolving conditions. 

Continued Services - We are committed to providing the following ongoing services from our core and expanded teams.

Occupational health services for the pharmaceutical and chemical industries

  • Health-based hazard assessments (OELs, PDEs, ADEs, OHCs, ASLs, etc.)   
  • Industrial hygiene technical assistance - remote evaluation of facilities and processes for worker exposure potential  
  • ICH M7 genotoxic impurities, nitrosamine and contaminant assessments 

Regulatory support for ingredient approvals

  • Global biocide, pesticide, food contact, food additive, food ingredient, dietary supplement, and cosmetic ingredient safety assessments and regulatory approval submissions 
  • Quality assurance consulting and oversight of toxicology and other studies to meet Good Laboratory Practice (GLP) requirements 
  • Safety and regulatory testing program design, management and scientific monitoring

Chemical compliance support

  • Global REACH (US, Canada, EU, Korea, China) support services
  • Global trade, import/export, dangerous goods transport, and related technical services
  • Safety Data Sheets (SDSs) to meet Global Harmonization System (GHS) requirements 

For further information, or if you have questions, please contact either of us or your SafeBridge contact.

Stay safe and remain healthy!!

Allan Ader, Ph.D., DABT 
Managing Director

Robert Sussman, Ph.D., DABT
Managing Director

<< go back